Comparative effectiveness of low-molecular-weight heparins after therapeutic interchange.
Management Case Studies describe approaches to real-life management problems in health systems. Each installment is a brief description of a problem and how it was dealt with. The cases are intended to help readers deal with similar experiences in their own work sites. Problem solving, not hypothesis testing, is emphasized. Successful resolution of the management issue is not a criterion for publication-important lessons can be learned from failures, too.
Bollinger
K A
KA
University of Iowa Hospitals and Clinics, Iowa City, USA.
Vermeulen
L C
LC
Davis
S N
SN
Geurkink
E A
EA
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017985:Dalteparin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017850:Economics, Pharmaceutical; D017984:Enoxaparin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D005569:Formularies as Topic; D006801:Humans; D008297:Male; D008875:Middle Aged; D010606:Pharmacy and Therapeutics Committee; D011655:Pulmonary Embolism / Q000517:prevention & control; D012189:Retrospective Studies; D013810:Therapeutic Equivalency; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D017984:Enoxaparin; D017985:Dalteparin